Imagin Medical Inc.
IMEXF
$0.00
$0.000.00%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -37.01% | -35.94% | -8.89% | -71.83% | 11.75% |
| Depreciation & Amortization | 475.00% | 471.67% | 459.02% | 218.97% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -61.33% | -58.20% | -19.47% | -14.93% | -8.53% |
| Operating Income | 61.33% | 58.20% | 19.47% | 14.93% | 8.53% |
| Income Before Tax | -54.97% | 28.80% | 101.12% | 44.80% | 1,128.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -54.97% | 28.80% | 101.12% | 44.80% | 1,128.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.97% | 28.80% | 101.12% | 44.80% | 1,128.54% |
| EBIT | 61.33% | 58.20% | 19.47% | 14.93% | 8.53% |
| EBITDA | 66.31% | 63.35% | 24.37% | 16.02% | 9.09% |
| EPS Basic | -58.42% | 34.29% | 101.01% | 51.54% | 1,033.59% |
| Normalized Basic EPS | -58.44% | 34.22% | 101.03% | 99.46% | 507.16% |
| EPS Diluted | -58.42% | 34.29% | 101.01% | 51.54% | 1,033.59% |
| Normalized Diluted EPS | -58.44% | 34.22% | 101.03% | 99.46% | 507.16% |
| Average Basic Shares Outstanding | 8.33% | 8.33% | 12.58% | 13.89% | 10.16% |
| Average Diluted Shares Outstanding | 8.33% | 8.33% | 12.58% | 13.89% | 10.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
